| Miss Sarah Fisher, | |
|
777 Bloomfield Ave, Clifton, NJ 07012-1242 | |
| (973) 594-0125 | |
| Not Available |
| Full Name | Miss Sarah Fisher |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 777 Bloomfield Ave, Clifton, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154545531 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Sarah Fisher, 450 Brook Ave, Passaic, NJ 07055-2445 Ph: () - | Miss Sarah Fisher, 777 Bloomfield Ave, Clifton, NJ 07012-1242 Ph: (973) 594-0125 |
News Archive
Researchers from Michigan State University and Stanford University have designed special nanoparticles which could break down an atherosclerotic plaque from within. This could prevent heart attacks say researchers. The study titled, "Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis," was published in the latest issue of the journal Nature Nanotechnology.
The last study participant has been recruited to Diamyd Medical's Phase II study in which cancer pain is treated with the drug candidate NP2 Enkephalin. The study is thus fully enrolled and results are expected to be reported in five to seven weeks.
New research documenting changes in the incidence and outcomes of end-stage renal disease in the U.S. between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans.
Previously unrecognized health benefits could be realized from fast action to reduce climate change and its consequences. For example, changes in energy and transport policies could save millions of lives annually from diseases caused by high levels of air pollution. The right energy and transport policies could also reduce the burden of disease associated with physical inactivity and traffic injury.
Phenomix Corporation today announced it has begun administering subjects in a Phase 1a clinical trial of PHX1766, the company's internally discovered, orally available NS3/4A protease inhibitor for the treatment of chronic hepatitis C virus (HCV) infection.
› Verified 3 days ago
Angela Graceffo, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 53 Orchard St, Clifton, NJ 07013 Phone: 973-773-7600 | |
Mrs. Daria Filipovic, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1135 Clifton Ave Ste 103, Clifton, NJ 07013 Phone: 973-988-4241 | |
Basya S Gutmann, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 199 Scoles Ave, Clifton, NJ 07012 Phone: 973-777-7638 Fax: 973-777-9311 | |
Ms. Cornelia Sherman, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1135 Clifton Ave Ste 103, Clifton, NJ 07013 Phone: 973-978-7188 | |
Brian Leguia, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1157 Main Ave, Clifton, NJ 07011 Phone: 973-800-0893 | |
Allyson Feinstein, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 777 Passaic Ave, Suite 365, Clifton, NJ 07012 Phone: 973-271-0700 Fax: 973-815-0737 |